Economist

Companies’ mixed messages about Delta variant’s impact

Companies are experiencing different degrees of impact from the recent COVID spike.

Sharp Rise in Job Postings Stipulating Vaccine Requirements: Report

The number of job openings posted on the Indeed hiring platform stipulating COVID-19 vaccines as a condition of employment has risen sharply in recent weeks, popping up in sectors with little interpersonal contact, according to the company’s research arm.

Plurality ‘Strongly Disapprove’ of Joe Biden’s Job Performance

A plurality of likely voters “strongly disapprove” of President Biden’s job performance, a Trafalgar Group survey released this week found.

China Won’t Be Taking Over the World

While the US has its problems, future global Chinese supremacy won’t be one. Far from being in a position of overwhelming strength, China and its Communist leadership face imminent multifront domestic crises that will threaten the existence not only of the Chinese Communist Party (CCP) but the existence of the Chinese state as a unified whole.

Chinese Communists Subsidized Trips For Western Journalists For Over 25 Years—CNN, NPR, WaPo, NYT, Reuters, ABC, NBC

Among the outlets sending journalists to participate in the trips are The New York Times, The Washington Post, National Public Radio (NPR), CNN, Reuters, POLITICO, and more.

The CDC Just Proved Milton Friedman Right (Again!)

The agency's 'temporary' eviction moratorium is a ticking time bomb that's getting bigger with every delay.

Private sector hiring slows sharply in July

ADP says US economy added 330,000 private-sector jobs in July.

America Still Values Free Speech: ‘People Are Too Easily Offended’

New poll shows more than half of Americans feel that the general public is "too sensitive" when it comes to speech.

‘Inflation Storm’ Looms as Expectations Hit 13-Year High, Consumer Sentiment Sinks

Americans expect more inflaton this year and remain uneasy about the direction of the economy, the University of Michigan’s survey of consumers showed Friday.

Ivermectin ‘Safe,’ ‘Effective’ COVID Treatment: WSJ Op-Ed

A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.

Latest news

- Advertisement -spot_img